C. Molecular and functional characterization of two distinct IGF binding protein-6 genes in zebrafish.
INSULIN-LIKE GROWTH FACTORS (IGFs) are evolutionarily conserved peptides that play fundamental roles in regulating development, growth, reproduction, and longevity. The biological actions of IGFs are mediated by the IGF-1 receptor, which is a member of the receptor tyrosine kinase family (20) . In addition to the IGF ligands and receptors, there exists another important component of the IGF system, the IGF binding proteins (IGFBPs). Six distinct IGFBPs, designated as IGFBP-1 to IGFBP-6, have been isolated and cloned from human and other species, and each represents an individual gene product (4, 9) . These proteins share relatively high amino acid sequence similarity, but each has distinct structural and biochemical properties, and each is subjected to differential developmental and hormonal regulation. These IGFBPs can act as carrier proteins in the bloodstream and can control the efflux of IGFs from the vascular space. The circulating IGF/IGFBP complexes prolong the half-life of IGFs and buffer their acute hypoglycemic effects. Since IGFBPs bind to IGFs with either equal or higher affinities than to the IGF receptors, locally expressed IGFBPs provide a means of localizing IGFs in specific cells and alter their biological activity by modulating their interaction with the IGF receptors. IGFBPs have been shown to both enhance and inhibit IGF-mediated cellular proliferation, differentiation, and apoptosis in a variety of mammalian cell cultures. IGF-independent actions have also been demonstrated for some IGFBPs (4, 9) .
IGFBP-6 is unique among the IGFBPs in that it has a 50-fold higher affinity for IGF-2 than IGF-1 (1) . Because of this binding preference, IGFBP-6 has been shown to inhibit IGF-2-induced cell proliferation, differentiation, and survival, but it has little effect on IGF-1 actions (1). Ligand-independent actions of IGFBP-6 on cell migration have been documented, although the underlying molecular mechanism(s) remains incompletely understood (10) . A recent study has reported that IGFBP-6 has a functional nuclear localization sequence that mediates its nuclear import in cultured cells (15) . Overexpression of IGFBP-6 inhibits rhabdomyosarcoma xenograft and neuroblastoma xenograft growth in vivo (11, 12) . Transgenic mice overexpressing IGFBP-6 in the central nervous system resulted in postnatal growth, brain development, and reproduction abnormalities (2) . Overexpression of IGFBP-6 in the brain resulted in dysregulation of energy homeostasis in mice (3) .
Recent studies using the zebrafish model have shed valuable insight into the in vivo functions of several IGFBPs, including IGFBP-1, 2, and -3 (16, 18, 21, 33) . Zebrafish embryos develop in water, thus eliminating the complication of maternal compensation. Fast developing and transparent zebrafish embryos make it easy to perform genetic manipulations and observe the phenotypic changes in organ formation in real time. Importantly, major components of the zebrafish IGF signaling pathway, including IGFs, IGF receptors, IGFBPs, and intracellular signal transduction network components, have been characterized and are highly conserved (7, 32) . Furthermore, many teleost fish, including zebrafish, may have experienced an additional genome-wide duplication event (25, 29) . As a result, fish often have two co-orthologs in contrast to a single copy gene in humans and other mammals. The retention of a particular pair of genes provided a unique opportunity to gain insights into the impact of evolution on gene structure and function.
The goal of this study was to identify and characterize the zebrafish IGFBP-6 gene(s), determine their spatial and temporal expression patterns, and elucidate their biological actions. A comparison of the structure of the IGFBP-6 gene from different vertebrate species will provide novel insight into our understanding of the evolution of the IGFBP gene family. An understanding of the zebrafish IGFBP-6 gene expression and function in early development will not only shed new insights into the developmental roles of this unique IGFBP, but also contribute to our knowledge of IGFBP-6 physiology in vertebrates in general.
MATERIALS AND METHODS
Animals. Zebrafish (Danio rerio) were kept at 28°C under a 14:10-h light-dark photoperiod and were fed twice daily. Zebrafish embryos were obtained from natural breeding and were kept at 28.5°C in embryo-rearing solution (31) supplemented with 0.003% (weight/ volume) 2-phenylthiourea (Sigma, St. Louis, MO). Embryos were staged following standard criteria (19) . At each stage, they were fixed in 4% (wt/vol) paraformaldehyde (PFA; Sigma, St. Louis, MO) in 1ϫPBS and stored at Ϫ20°C in 100% methanol or frozen in liquid nitrogen and stored at Ϫ80°C for further analysis. All experiments were conducted at Ocean University of China with approved protocols. These protocols also met the guidelines established by the University of Michigan Committee on the Use and Care of Animals.
Molecular cloning and sequence analysis. Using human IGFBP-6 amino acid sequence as a query, we searched the zebrafish genome database (http://www.ensembl.org/Danio_rerio/blastview) by BLASTX and BLASTN for candidate sequences. Two zebrafish IGFBP-6-like sequences were found. Their full-length cDNAs were determined by 5Ј-and 3Ј-rapid amplification of cDNA ends (RACE) as described below. Amino acid sequences were aligned by CLUSTALW using the GCG program FASTA. Best-fit model of protein evolution was obtained by Prottest (http://darwin.uvigo.es/software/prottest.html). Gene structure was analyzed using the Genscan program (http:// genes.mit.edu/GENSCAN.html).
Phylogenetic analysis was generated by the neighbor-joining method using the MEGA 3.1 software (Biodesign, Tempe, AZ). The reliability of the estimated tree was evaluated by the bootstrap method with 5,000 replications. We also constructed a phylogenetic tree using the maximum likelihood (ML) method with the PhyML V2.4.4 program (13) . Synteny analysis was carried out based on Danio rerio Zv6 (http://www.ensembl.org/Danio_rerio/index.html) and Homo sapiens Build 36.3 (http://www.ensembl.org/Homo_sapiens/index.html) and from zebrafish and human synteny map. Genomic structure was determined by comparing the full-length cDNA sequence and the zebrafish genome sequence (http://www.ensembl.org/Danio_rerio/ index.html).
For RACE and RT-PCR, total RNA was isolated from adult zebrafish and embryos using TRIzol Reagent (Invitrogen, Carlsbad, CA). One microgram RNA was converted into cDNA using M-MLV (Promega, Madison, WI) with oligo(dT)18 primer (Sangon, Shanghai, China). The 5Ј and 3Ј RACE were performed using the SMART RACE cDNA amplification kit (Clontech, Mountain View, CA) following the manufacturer's instructions. Nested primers used in the IGFBP-6a 5Ј RACE were 5Ј-TGAAGGACTGTAAAGGCTTGTGGC-3Ј and 5Ј-CGCTGC-TACATGAGATTGATCCATC-3Ј; Nested primers used in the IG-FBP-6a 3Ј RACE were 5Ј-AGCACCACTACCTCCACTGAACAT-3Ј and 5Ј-TGTCTCTGCCTCATTTGCTAGCTC-3Ј; Nested primers used in the IGFBP-6b 5Ј RACE were 5Ј-GTCTTGCACCAAGCTGAAAT-CATCC-3Ј and 5Ј-CAAGACACTGTTGAGCAGCTTACG-3Ј; and Nested primers used in the IGFBP-6b 3Ј RACE were 5Ј-CCAGAAAT-AGCATCAGCCACGTAC-3Ј and 5Ј-AGAACCTGAGACCTGGACG-CAAGAT-3Ј.
Primers used in confirming the extra exon, extron 5, of the igfbp-6b were 5Ј-GGATGATTTCAGCTTGGTGCAAGAC-3Ј and 5Ј-AGCG-GCATAAAATACATCCAGTTGG-3Ј).
Quantitative real-time RT-PCR (qRT-PCR) and whole mount in situ hybridization (WISH).
One microgram RNA was converted into cDNA using M-MLV and oligo(dT)18 primer. qRT-PCR was carried out on iCycler iQ5 Multicolor real-time PCR detection system (Bio-Rad, Hercules, CA) according to the manufacturer's instructions. Primer sequences for qRT-PCR were ␤-actin: 5Ј-ACAGGGAAAAGATGACA-CAG-3Ј and 5Ј-AGAGTCCATCACGATACCAG-3Ј; IGFBP-6a: 5Ј-CTCCGCCTACAGACTATGA-3Ј and 5Ј-GTCCTGAACCGAGT-GAAT-3Ј; and IGFBP-6b: 5Ј-CCACATCCTTCACACAGTGG-3Ј and 5Ј-ACCGACACTGCTTTTTCCTG-3Ј. qPCR was performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA). ␤-actin amplification efficiency was similar to that of IGFBP-6a and IGFBP-6b. Results were analyzed using the 2 Ϫ⌬⌬CT method (22) . Each experiment was repeated in triplicate.
For WISH, embryos were fixed in 4% PFA at 24 h postfertilization (hpf). Digoxigenin-labeled RNA probes were synthesized in vitro using T7 or T3 RNA polymerase (Promega, Madison, WI). The following probes were used: Egr2b, Emx1, MyoD, and Rx1. WISH protocols were essentially the same as described in Li et al. (21) . Images of zebrafish embryos were recorded with a Nikon DS-5Mc digital camera mounted to a Nikon SMZ1500 Fluorescence stereomicroscope (Melville, NY).
Construction of expression plasmids. For in vivo functional studies, several IGFBP-6a and IGFBP-6b expression constructs were engineered. First, DNA fragments containing the entire open reading frame (ORF) of zebrafish IGFBP-6a or IGFBP-6b, in which the stop codon was mutated, was generated by PCR (IGFBP-6a: forward primer 5Ј-CCATCGATGCCACCATGTCTCTGCCT-CATTTGCT-3Ј and reverse primer 5Ј-CGGAATTCCAGCGCT-GCTACATGAGATTGAT-3Ј; IGFBP-6b: forward primer 5Ј-CCATCGATGCCACCATGTCTTTCCTTTCCAACTT-3Ј and reverse primer 5Ј-CGGAATTCCCTCTCCGTCACATGGTA-AAAT-3Ј). The amplified products were digested with EcoR I and Cla I and subcloned into the pCS2-eGFP vector (21) , resulting in pCS2ϩIGFBP-6a:eGFP and pCS2ϩIGFBP-6b:eGFP, respectively. Both constructs were verified by DNA sequencing.
Microinjection experiment. For mRNA synthesis, the plasmids were linearized by digestion with the appropriate restriction enzymes. Capped RNAs were synthesized with a SP6 Message Machine kit (Ambion, Austin, TX) using the linearized plasmid DNA as template. The mRNA was diluted to 0.4 g/l with Phenol red (Sigma, St. Louis, MO) and injected with a volume of 1.5 nl into 1-to 2-cell stage embryos as previously reported (33) . Each experiment was carried out with two controls, wild type (no injection) and GFP mRNA-injected embryos. After injection, embryos were kept in embryo rearing solution and kept at 28.5°C. Body length was quantified with MBRuler 5.1 software (Markus Bader, Germany), measuring the curvilinear distance from the forebrain boundary to the tail. Somite numbers were counted manually.
Western immunoblot. Thirty embryos from each treatment group were dechorionated, deyolked, and homogenized in 20 l of RIPA buffer (50 mM Tris ⅐ HCl, 150 mM NaCl, 2 mM EGTA, 0.1% Triton X-100, pH 7.5) containing 10 g/ml aprotinin, 10 g/ml leupeptin, 10 g/ml pepstatin, and 100 mM PMSF. The homogenates were centrifuged to pellet cellular debris, and the supernatant was retained. Each sample was subjected to SDS-PAGE (12.5%) and transferred to Immobilon-P membrane (Millipore, Billerica, MA). Western immunoblot analysis was performed as described previously (6) using a GFP antibody (Torrey Pines Biolabs, Houston, TX).
Statistics. Data were expressed as the means Ϯ SE. Differences among groups were analyzed by one-way ANOVA followed by Sidak's post hoc test for multiple comparisons (SPSS, SPSS, Chicago, IL). The criterion for statistical significance was P Ͻ 0.05.
RESULTS

Identification and cloning of two IGFBP-6 genes in zebrafish.
We searched the zebrafish GenBank database using the human IGFBP-6 sequence (GenBank accession no. CAA07346.1) as a query and found two distinct IGFBP-6-like proteins (GenBank accession no. XM_679868 and XM_688133). These two predicted proteins both displayed significant sequence identities to human IGFBP-6, but they are clearly distinct from each other. For reasons described hereafter, we named these two genes as igfbp-6a and igfbp-6b.
Using 5Ј-and 3Ј-RACE, their full-length cDNAs were determined. The full-length IGFBP-6a cDNA is 1,249 bp (GenBank accession no. EU005245). It contains an ORF of 585 bp encoding a protein of 194 aa, a 108 bp 5Ј-UTR, and a 556 bp 3Ј-UTR. There is a typical polyadenylation [poly(A)] signal sequence AATAAA and 30 bp of poly(A) tail at the end of the 3Ј UTR. The encoded protein has a putative signal peptide of 24 aa and a mature protein of 170 aa. The full-length IGFBP-6b cDNA is 1,266 bp, and it contains an ORF of 612 bp, which encodes a protein of 203 aa. (GenBank accession no. EU005246). The encoded protein has a 26 aa signal peptide and a mature protein of 177 aa. The 5Ј-UTR is 159 bp and 3Ј-UTR is 495 bp, including a typical poly(A) signal sequence AATAAA and 26 bp of poly(A) tail.
Comparison of the primary sequences of zebrafish IG-FBP-6a and IGFBP-6b with those of other known vertebrate IGFBPs revealed that they share the highest sequence identity to that of IGFBP-6. These two zebrafish IGFBPs are clearly distinct to the known zebrafish IGFBPs. Zebrafish IGFBP-6a is only 26%, 27%, 34%, and 34% identical to zebrafish IGFBP-1s, IGFBP-2, IGFBP-3, and IGFBP-5 at the amino acid level (Table  1) . Zebrafish IGFBP-6b shares 24 -28%, 25%, 35%, and 32% sequence identity to that of zebrafish IGFBP-1s, IGFBP-2, IGFBP-3, and IGFBP-5, respectively. Among the known teleost IGFBPs, the IGFBP-6a shares 49% identity to that of rainbow trout and Atlantic salmon IGFBP-6. The IGFBP-6b has 76% and 75% identity to that of trout and salmon IGFBP-6. The two zebrafish IGFBP-6s show comparable sequence identities to human IGFBP-5 and IGFBP-6 (37-32%). Their sequence identities to human IGFBP-1 and IGFBP-2 are much lower (Table 1) .
While all mammalian IGFBP-6 have 10 cysteine residues in the N-domain, both zebrafish IGFBP-6s only have 6 cysteine residues in this region. Zebrafish IGFBP-6a and IGFBP-6b also have 6 cysteine residues in the conserved C-terminal domain, and 1 in the signal peptide (Fig. 1A) . Like mammalian IGFBP-6, both zebrafish IGFBP-6s have a thyroglobulin type 1 motif and a CWCV motif in the C-terminal domain, but they lack the GCGCC-XXC motif present in IGFBP-1-5. Zebrafish IGFBP-6a has an estimated molecular mass of 18.7 kDa. IGFBP-6b has an estimated molecular mass of 19.5 kDa. There are 5 O-glycosylation sites in the L-domain region of human IGFBP-6 (24). Analysis using an online program (http://ogpet.utep.edu/OGPET/), which can predict all five O-glycosylation sites in the L-domain region of human IGFBP-6, failed to find any consensus O-glycosylation sites in zebrafish IGFBP-6a and IGFBP-6b. Analysis using the NetOGlyc 3.1 server (http://www.cbs.dtu.dk/services/NetOGlyc/), however, suggests that there are several potential O-glycosylation sites: Thr97, Thr105, Thr111, and Thr112 in zebrafish IGFBP-6a and Thr57, Thr105, Ser106, Thr108, Thr114, Ser119, and Ser121 in IGFBP-6b. There is no consensus N-glycosylation site in mature IGFBP-6a and IGFBP-6b.
We next performed phylogenetic analysis using the fulllength amino acid sequences of known vertebrate IGFBPs. As shown in Fig. 1B , a phylogenetic tree generated by the neighbor-joining method grouped the two newly identified proteins into the IGFBP-6 clade with high bootstrap value, indicating that they are indeed co-orthologs of human IGFBP-6 (Fig. 1B) . Similar results were obtained using the maximum likelihood method (Supplemental Fig. 1 ). In agreement with a recent report (26) , our phylogenic analysis indicated that the previously reported rainbow trout and salmon IGFBP-3 are grouped into the IGFBP-2 clade rather than in the IGFBP-3 clade.
The two zebrafish IGFBP-6 genes have similar genomic structure and show high synteny to the human IGFBP-6 gene. The genomic structure of zebrafish igfbp-6a and igfbp-6b are shown in Fig. 2A . Like their mammalian counterparts (8), zebrafish igfbp-6a contains 4 exons and 3 introns and spans 6.1 kb (Fig. 2A) . Exon 1 contains the 5Ј UTR, signal peptide, all of the N-domain, and part of the L-domain. Exon 2 is very small, and it encodes part of the L-domain. Exon 3 and 4 contain the C domain and the 3Ј UTR. The zebrafish igfbp-6b is ϳ3.9 kb. Comparison of the exon lengths of the two zebrafish igfbp-6 genes indicates a high degree of conservation. The zebrafish igfbp-6b, however, has an extra exon in its 3Ј end, which encodes a portion of the 3Ј UTR ( Fig. 2A) .
To explore the possible synteny relationship among the zebrafish igfbp-6s and the human IGFBP-6, we analyzed genes surrounding the igfbp-6 loci in the zebrafish and human genomes. While igfbp-6a is located to linkage group (LG) 11, igfbp-6b is mapped to LG 23 (Fig. 2B) . The human IGFBP-6 gene resides on chromosome 12 (8) . Further analysis of the surrounding regions revealed that igfbp-6a and 12 other zebrafish genes (CYP27B1, NPFF1, HNRNPA1, PIP5K2C, DGKA, TMEM 4, SMUG 1, HOXC-6b, HOXC-11b, HOXC12b, HOXC-13b, and RARG) located on LG11 have orthologs on human chromosome 12 (8) . Similarly, in the proximity of the igfbp-6b locus, 14 other zebrafish genes (HOXC-3a, HOXC-4a,  HOXC-5a, HOXC-6a, HOXC-8a, HOXC-9a, HOXC-10a,  HOXC-11a, HOXC-13a, PIP5K2C , ADMR, ZBTB 39, CSAD, RARG, SILV b) have their orthologs located near the human IGFBP-6 locus on chromosome 12. This conserved synteny The left numbers show identities between zebrafish IGFBP-6a and other IGFBPs, and the right number show identities between zebrafish IGFBP-6b and other IGFBPs. *Compared with corresponding partial sequences. †Iden-tities between zebrafish IGFBP-1a and zebrafish IGFBP-6 s. ‡Identities between zebrafish IGFBP-1b and zebrafish IGFBP-6 s. §Identities between zebrafish IGFBP-6a and IGFBP-6b. strongly suggests that igfbp-6a and igfbp-6b are co-orthologs of the human IGFBP-6 gene.
The two igfbp-6 genes show distinct temporal and spatial expression patterns. The temporal and spatial expression patterns of igfbp-6a and igfbp-6b were determined by qRT-PCR and are shown in Fig. 3 . Both IGFBP-6a and IGFBP-6b transcripts were detectable by qRT-PCR throughout embryogenesis and the larval stages, albeit at low levels (Fig. 3A) . The IGFBP-6a mRNA levels were relatively constant between 24 to 96 hpf. The IGFBP-6b mRNA levels were low during the initial 48 h. They became significantly higher at 72 and 96 hpf. Whole mount in situ hybridization analysis failed to show any specific hybridization signal (data not shown) despite considerable efforts, probably due to the relatively low levels of expression of these genes during early development. In the adult stage, IGFBP-6a mRNA was most abundantly expressed in the muscle (Fig. 3B) . The levels of IGFBP-6a mRNA were very low in the gill and testis, ϳ10-fold lower than those of muscle. The IGFBP-6a mRNA levels were barely detectable in brain, eye, heart, stomach ϩ intestine, spleen, liver, ovary, and kidney (Fig. 3B) . In comparison, the levels of IGFBP-6b mRNA were very high in the brain, heart, and muscle. IGFBP-6b mRNA was very low or barely detectable in other tissues examined (Fig. 3B) .
Overexpression of IGFBP-6a and IGFBP-6b inhibits growth and development.
To determine and compare the biological activities of zebrafish IGFBP-6a and -6b, capped mRNAs encoding zebrafish IGFBP-6a and IGFBP-6b were generated and introduced into zebrafish embryos by microinjection. The successful expression of IGFBP-6a and IGFBP-6b were verified by examining the GFP signal under fluorescent microscopy (Fig. 4A ) and by Western immunoblot (Fig. 4B) . As shown in Fig. 4C , embryos injected with either zebrafish IGFBP-6a or IGFBP-6b mRNA were morphologically normal, but they were smaller in size and developmentally delayed compared with GFP mRNA injected or wild-type control embryos. The body lengths of IGFBP-6a and IGFBP-6b mRNA injected embryos were 2.163 Ϯ 0.015 mm (n ϭ 48) and 2.121 Ϯ 0.009 mm (n ϭ 47) (Fig. 4D ), both were significantly smaller than the wild-type control group (2.249 Ϯ 0.013 mm, n ϭ 46) and the GFP mRNA-injected group (2.277 Ϯ 0.012 mm, n ϭ 52) (P Ͻ 0.001). As shown in Fig. 4E , injection of IGFBP-6a or IGFBP-6b mRNA also significantly (P Ͻ 0.001) reduced the somite numbers from 22.67 Ϯ 0.36 somites of the wild-type control group (n ϭ 46) and 22.95 Ϯ 0.38 of the GFP mRNA-injected group (n ϭ 52) to 21.31 Ϯ 0.34 (n ϭ 48) somites in the IGFBP-6a mRNA-and 20.26 Ϯ 0.39 (n ϭ 47) in the IGFBP-6b mRNA-injected group. We next performed in situ hybridization to determine any potential defects in patterning. Overexpression of either IGFBP-6a or IGFBP-6b did not alter the brain patterning, as indicated by mRNA expression patterns of egr2b (labeling third and fifth rhombomeres), emx1 (forebrain), rx1 (retina), and myoD (somite) (Fig. 5) . These data suggest that the two IGFBP-6 isoforms have comparable biological activities. When expressed, they both inhibited embryonic growth and developmental rates without notable effects on cell fate determination or patterning.
DISCUSSION
In this study, we have identified and characterized two structurally distinct IGFBP-6 genes from zebrafish. Structural, phylogentic, and comparative genomic analyses indicate that they are co-orthologs of the human IGFBP-6 gene. Our molecular and functional studies suggest that the duplicated zebrafish IGFBP-6 genes have undergone subfunctionalization partitioning by evolving distinct gene expression patterns.
The conclusion that zebrafish igfbp-6a and igfbp-6b are two co-orthologs of human IGFBP-6 is supported by several lines of evidence. Comparison of their primary sequence with those of other known fish IGFBPs revealed that they share the highest sequence identity to that of IGFBP-6. Phylogenetic analysis using two independent methods have firmly placed the zebrafish igfbp-6a and igfbp-6b gene clustering with other vertebrate IGFBP-6s. In humans, the IGFBP-6 is located on chromosome 12, next to the RARG gene and the CSAD. In its proximity are the HOXC gene cluster, PIP5K2C, and CYP27B1, among others. In the zebrafish genome, zebrafish igfbp-6a and igfbp-6b are located on LG 11 and 23, respectively. In their neighborhoods, there are RARG, PIP5K2C, CYP27B1, and a cluster of HOXC genes. In addition to these genes, we were able to identify other orthologous genes between zebrafish LG9 and human chromosome 2. This conserved synteny has provided very strong evidence that zebrafish igfbp-6a and igfbp-6b are co-orthologs of the human IGFBP-6 gene. The presence of two duplicated IGFBP-6 genes may not be unique to zebrafish. While zebrafish IGFBP-6b has 76% and 75% identity to that in trout and salmon IGFBP-6, zebrafish IGFBP-6a only shares 49% identity to that of rainbow trout and Atlantic salmon IGFBP-6. Judging from these divergences, the published rainbow trout IGFBP-6 and salmon IGFBP-6 are more closely related to zebrafish IGFBP-6b. It is possible that there may be more IGFBP-6 genes in salmonid fish.
The finding of two functional zebrafish IGFBP-6 genes has provided us with the opportunity to gain insight into how the IGFBP-6 genes may have evolved through partitioning of ancestral functions. After duplication, each gene copy can follow a separate evolutionary fate. It has been postulated that nonfunctionalization is the fate for the majority of the duplicate genes with only 20% or so being retained (25, 29) . Subfunction partitioning is common among the retained duplicated genes (25, 29) . Diversified expression profiles have been documented in duplicated zebrafish igfbp-1 genes (18). In those cases, it has been suggested that the changes in the regulatory modules in each of the two duplicates may have been sufficient to allow their distinct expression patterns. The duplicated zebrafish igfbp-6 genes are yet another example of temporal and spatial subfunctioning partitioning. In mammals and other teleost fish, IGFBP-6 mRNA is found in a wide variety of tissues. For instance, rainbow trout IGFBP-6 mRNA was expressed in almost all tissues analyzed with the strongest expression in the spleen, gills, brain, and stomach (17) . IGFBP-6 mRNA also has a ubiquitous presence in rat and human (5, 28) . In the adult zebrafish, IGFBP-6a mRNA is highly expressed in the muscle. Only very low levels of IGFBP-6a mRNA are found in non- muscle tissues. In comparison, IGFBP-6b mRNA is abundantly expressed in brain, heart, and muscle. During embryogenesis, the two genes exhibit distinct temporal patterns. The IGFBP-6a mRNA levels are low during embryogenesis. The IGFBP-6b mRNA levels, on the other hand, are low during the first 48 h. They become higher at 48 hpf and were maintained at high levels thereafter. These data suggest that the duplicated igfbp-6 genes have evolved distinct spatial and temporal expression patterns. Compared with other IGFBPs (21, 33, 34) , however, the levels of IGFBP-6a and IGFBP-6b mRNA appeared to be considerably lower. In fact, they were under the detection limit of in situ hybridization and were detected by RT-PCR with very high cycles (data not shown). Maures et al. (23) reported both IGF-1 and IGF-2 mRNAs are expressed in most, if not all cells, throughout the embryogenesis. In adult zebrafish, IGF-2 mRNA is highly expressed in the skeletal muscle, brain, and heart. It is possible that the high levels of IGFBP-6a and IGFBP-6b in these tissues may act as local regulators of IGF availability and biological activity in these adult zebrafish tissues.
Subfunction partitioning can involve protein structural changes (25) . The duplicated zebrafish IGFBP-6s have clearly diverged as they are only 50% identical to each other in primary sequence. Despite divergences in their primary sequences, important motifs and domains are clearly conserved in the two zebrafish IGFBP-6s. Like all known IGFBPs, they possess a CWCV motif and 6 cysteine residues in their C domains. Mutational studies with human IGFBP-6 have indicated that Pro93/Leu94/Leu97/Leu98 are critical for IGF binding because changing them into Ala resulted in a more than 10,000-fold reduction in binding affinity for IGFs (10) . These residues are perfectly conserved in the zebrafish IGFBP-6a (Pro80/Leu81/Leu84/Leu85) and IGFBP-6b (Pro88/Leu89/ Leu92/Leu93). IGFBP-6 is unique among the IGFBP family in that it preferentially binds to IGF-2 (1). Headey et al. (14) have mapped the IGF-2 binding surface in human IGFBP-6. It includes Leu174, Val178, Gly181, Val187, Asn189, Cys190, Gly194, Arg199, Ser203, Ser204, Gln205, and Gly206. In addition, Arg164, Leu167, Leu171, Ala182, Pro188, and Cys201 are also believed to be part of the binding site, but this could not be verified experimentally. Most of the above residues are conserved in zebrafish IGFBP-6a and IGFBP-6b. The perfectly conserved residues are Arg121 (corresponding to Arg164 in human), Leu124, Leu128, Val135, Pro145, Asn146, Cys147, Gly151, Cys158, Ser160, Ser161, and Gly163 in zebrafish IGFBP-6a; Arg130, Leu133, Leu137, Leu140, Pro154, Asn155, Cys156, Gly160, Cys167, Ser169, Ser170, and Gly172 in zebrafish IGFBP-6b. There are also several conserved substitutions. Val187 in human IGFBP-6 is changed into Ile in IGFBP-6a (residue 144) and IGFBP-6b (residue 153), and Arg199 is changed into Lys in zebrafish IGFBP-6a (Lys156) and IGFBP-6b (Lys165). Likewise, Val135 in human IGFBP-6 is changed into Ile144 in zebrafish IGFBP-6. Leu174 in human IGFBP-6 is changed into Ile131 in zebrafish IGFBP6a. These results suggest that the IGF-2 specific biding site is highly conserved in zebrafish IGFBP-6a and IGFBP-6b. Human IGFBP-6 has been reported to possess a functional nuclear localization signal (HRGFYRKRQCRSSQGQRRG-the bold letters indicate charged residues) in the N domain, which mediates its nuclear import (15 ). Whether the zebrafish IGFBP-6 genes can be found in the nucleus awaits further functional tests.
In vitro studies using a variety of mammalian cell culture systems have indicated that mammalian IGFBP-6 has a pre- Fig. 5 . Ectopic expression of IGFBP-6a and IGFBP-6b has no effect on cell fate and patterning. Whole mount in situ hybridization images of wild-type, GFP mRNA, IGFBP-6a, and IGFBP-6b mRNA-injected embryos at 24 hpf; egr2b expression in the third and fifth rhombomeres of the hindbrain; emx1 expression in the forebrain; rx1 expression in the retina; myoD expression in the somatic myotome. Similar patterns were observed in all embryos examined in each group (n ϭ 20 -25).
dominantly inhibitory effect on IGF-2 actions (1), although IGF-independent action in promoting cancer cell migration has also been reported (10) . As mentioned in the introduction, published literature suggests that mammalian IGFBP-6 is primarily an inhibitory IGFBP in vivo. In good agreement with these findings, injection of IGFBP-6a and IGFBP-6b mRNA into zebrafish embryos caused significant decreases in body size and somite number. These overexpression experiments suggest that IGFBP-6a and IGFBP-6b are inhibitory proteins and that they probably act by binding to IGF and inhibiting IGF actions in vivo. Overexpression of either zebrafish IGFBP-6a or IGFBP-6b had no notable effects on cell fate determination or patterning, suggesting that they are primarily involved in growth and temporal development. Our functional analysis using transgenic zebrafish suggests that the inhibitory action of IGFBP-6 is conserved across species. More importantly, overexpression of zebrafish IGFBP-6a and IGFBP-6b in zebrafish embryos had nearly identical phenotypes, i.e., they caused a similar decrease in the growth and developmental rates. Our results also suggest that IGFBP-6a and IGFBP-6b are not major players in the IGF signaling pathway during early embryogenesis because of their low expression levels during early development. In addition, overexpression of IGFBP-6a and IGFBP-6b only caused modest decreases in growth and developmental rates compared with zebrafish IGFBP-1 and IG-FBP-2 (18, 34) .
Genomic studies have suggested that a genome duplication event occurred in the teleost lineage ϳ350 million years ago, prior to the beginning of the teleost radiation (25, 29) . Although most of the duplicated genes have been lost, a substantial percentage of the duplicates have been retained. Recent studies have shown that most, if not all the major components in the fish IGF signaling pathway, are retained as duplicates in the zebrafish genome. Zebrafish contain two igf-1r genes and two insulin receptor genes (27, 30) . Recently, we have found that there are two igfbp-1 genes (18), two igfbp-2 genes, and two igfbp-5 genes in zebrafish (34) . In this study, we have demonstrated the presence of two functional IGFBP-6 genes in zebrafish. This high rate of gene retention in genes belonging to the IGF signaling pathway in the ray-fin fish is intriguing. Most teleost fishes do not reach a static adult size but continue to grow indeterminately well beyond puberty. Given the known importance of the IGF signaling pathway in growth regulation, the retention of the duplicated IGF ligands, receptors, and IGFBPs may play important roles in the continuous growth pattern in teleosts.
Perspectives and Significance
IGFBP-6 is unique among IGFBPs because it preferentially binds to IGF-2 over IGF-1. In this study, we identified and characterized two functional IGFBP-6 genes in zebrafish. Structural, phylogenetic, and comparative genomics analyses indicate that they are co-orthologs of the human IGFBP-6 gene, likely resulting from a genome-wide duplication event before the beginning of the teleost radiation. Gene expression and functional analysis suggest that the two IGFBP-6 genes have undergone subfunctionalization partitioning by evolving distinct gene expression patterns, while their protein functionalities remain similar. Zebrafish IGFBP-6a and IGFBP-6b are conserved regulatory protein, and they inhibit embryo growth and development when overexpressed. This study has not only provided novel insights into the functional evolution of IGFBP-6 but also demonstrated the utility of the zebrafish model system in studying IGFBP physiology. Further studies in zebrafish, focusing on determining whether the two zebrafish IGFBP-6 genes possess different ligand-binding, cellular localization, and IGF-independent properties, will be needed to elucidate the molecular basis of the duplicated IGFBP-6 genes.
